Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Capital Expenditures (2023)

Mangoceuticals (MGRX) has disclosed Capital Expenditures for 1 consecutive years, with $3519.0 as the latest value for Q1 2023.

  • Quarterly Capital Expenditures changed N/A to $3519.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $3519.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $3519.0 for FY2023, N/A changed from the prior year.
  • Capital Expenditures hit $3519.0 in Q1 2023 for Mangoceuticals.
  • In the past five years, Capital Expenditures ranged from a high of $3519.0 in Q1 2023 to a low of $3519.0 in Q1 2023.